Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.07 | 38.93 |
| PEG Ratio (TTM) | 0.00 | 8.60 |
| P/S Ratio (TTM) | 0.11 | 4.51 |
| P/B Ratio (TTM) | 0.01 | 7.66 |
| P/FCF Ratio (TTM) | -0.48 | 30.56 |
| Price to 5YR AVG Earnings Ratio | 0.00 | 48.62 |
| Price to 5YR AVG FCF Ratio | -0.37 | 37.18 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -10.85% | 10.56% |
| ROE (TTM) | -12.68% | 9.17% |
| Net Profit Margin (TTM) | -38.25% | 10.69% |
| ROIC 5YR AVG | -16.89% | 28.56% |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 31.59% | 70.21% | 79.36% |
| Revenue | 30.49% | 12.39% | 3.71% |
| Net Income | -114.53% | -72.03% | -143.23% |
| Cash Flow | -488.13% | 6.31% | -61.90% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 8.75 | 0.88 |
| Quick Ratio (TTM) | 8.75 | 0.83 |
| D/E Ratio (TTM) | 0.01 | 0.65 |
| Interest Coverage (TTM) | -17.86 | 13.42 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 0.22 | 5.90 |
| LTL to 5YR AVG FCF | -0.09 | 4.60 |
| Shares Outstanding Growth 5YR AVG | 1,697.96% | 0.04% |